![]()
|
|
||||||||
(Received for publication, June 5, 1996, and in revised form, July 31, 1996)
From the Sarcoplasmic reticulum vesicles were treated with
1,2-cyclohexanedione (CHD) in sodium borate (pH 8.0). The
Ca2+-ATPase activity was completely inhibited. Inhibition
of Mg·ATP and Mg·ADP binding to the high affinity ATP binding site
as well as inhibition of phosphorylation with ATP occurred
simultaneously with the inhibition of the Ca2+-ATPase
activity. Phosphorylation with acetyl phosphate was not inhibited. The
Ca2+-ATPase was strongly protected by Mg·ATP, Mg·ADP,
and Mg·AMP against this inhibition. Binding of acetyl phosphate or
Pi to the enzyme gave no protection. Phosphorylation with
acetyl phosphate also had no protective effect. Peptide mapping of the
tryptic digests, detection of peptides containing CHD-modified arginyl
residues with Girard's reagent T, and sequencing revealed that
Arg-489, Arg-505, and Arg-678 were modified with CHD. Arg-489 and
Arg-678 were almost completely protected by Mg·ATP against this
modification, but partially protected by prelabeling with fluorescein
5-isothiocyanate, which occupies the adenosine binding region in the
ATP binding site. In contrast, Arg-505 was slightly protected by
Mg·ATP and almost completely protected by prelabeling with
fluorescein 5-isothiocyanate. Taken together, these findings suggest
that Arg-489 and Arg-678 are located in or near the region occupied by
the triphosphate moiety of ATP, either or both of these residues being
in or close to the region occupied by the
Volume 271, Number 46,
Issue of November 15, 1996
pp. 28933-28941
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
MODIFICATION WITH 1,2-CYCLOHEXANEDIONE
§
,
,
,
and
Department of Biochemistry and the
§ Third Department of Internal Medicine, Asahikawa Medical
College, Asahikawa 078, Japan
-phosphoryl group in the
high affinity ATP binding site and involved in the CHD-induced
inhibition of this enzyme and that Arg-505 is very close to (but
slightly out of) the adenosine binding region in the ATP binding site.
The acetyl phosphatase activity and phosphorylation with Pi
were also inhibited by the CHD treatment, but the inhibitions were
considerably slower than those described above. This suggests that the
arginyl residues involved in these inhibitions are distinct from that involved in the inhibition of the Ca2+-ATPase activity.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. Moncoq, C. A. Trieber, and H. S. Young The Molecular Basis for Cyclopiazonic Acid Inhibition of the Sarcoplasmic Reticulum Calcium Pump J. Biol. Chem., March 30, 2007; 282(13): 9748 - 9757. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamasaki, T. Daiho, T. Saino, and T. Kanazawa Modification of Histidine 5 in Sarcoplasmic Reticulum Ca2+-ATPase by Diethyl Pyrocarbonate Causes Strong Inhibition of Formation of the Phosphoenzyme Intermediate from Inorganic Phosphate J. Biol. Chem., December 5, 1997; 272(49): 30627 - 30636. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saino, T. Daiho, and T. Kanazawa Modification of Arginine-198 in Sarcoplasmic Reticulum Ca2+-ATPase by 1,2-Cyclohexanedione Causes Inhibition of Formation of the Phosphoenzyme Intermediate from Inorganic Phosphate J. Biol. Chem., August 22, 1997; 272(34): 21142 - 21150. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |